Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Feb:145:39-44.
doi: 10.1016/j.brainresbull.2018.08.024. Epub 2018 Nov 17.

Neurological manifestations in Onchocerca volvulus infection: A review

Affiliations
Review

Neurological manifestations in Onchocerca volvulus infection: A review

An Hotterbeekx et al. Brain Res Bull. 2019 Feb.

Abstract

Human onchocerciasis, caused by infection by the filarial nematode Onchocerca volvulus, is a major neglected public health problem that affects millions of people in the endemic regions of sub-Saharan Africa and Latin America. Onchocerciasis is known to be associated with skin and eye disease and more recently, neurological features have been recognized as a major manifestation. Especially the latter poses a severe burden on affected individuals and their families. Although definite studies are awaited, preliminary evidence suggests that neurological disease may include the nodding syndrome, Nakalanga syndrome and epilepsy but to date, the exact pathophysiological mechanisms remain unclear. Currently, the only way to prevent Onchocera volvulus associated disease is through interventions that target the elimination of onchocerciasis through community distribution of ivermectin and larviciding the breeding sites of the Similium or blackfly vector in rivers. In this review, we discuss the epidemiology, potential pathological mechanisms as well as prevention and treatment strategies of onchocerciasis, focusing on the neurological disease.

Keywords: Epilepsy; Neurological features; Onchocerca volvulus.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
This figure is adapted from the WHO and show the worldwide distribution of Onchocerciasis and the countries with ongoing transmission in 2013, http://www.who.int/onchocerciasis/distribution/en/.
Fig. 2
Fig. 2
This is an electroencephalographic recording from scalp electrodes of a 15-year-old male Ugandan adolescent with Onchocerca associated epilepsy. He has had symptoms for at least 3 years. The recording shows generalized epileptiform discharges. Recording by Dr Richard Idro.

Similar articles

Cited by

References

    1. Boatin B. The onchocerciasis control programme in West Africa (OCP) Ann. Trop. Med. Parasitol. 2008;102(Suppl 1):13–17. Epub 2008/09/26. - PubMed
    1. Boussinesq M. Human onchocerciasis in Africa. Med. Trop. (Mars) 1997;57(4):389–400. Epub 1997/01/01. L’onchocercose humaine en Afrique. - PubMed
    1. Sato Y.T.Y., Sakai K., Suzuki S., Kato S., Nishi M. International OAE Workshop. 2017. Household burdens of and community response to nodding syndrome in northern Uganda. Abstract 3.
    1. JHF R. World Health Organization; Geneva: 2004. The Global Burden of Onchocerciasis in 1990; p. 2004. world health organization.
    1. Katabarwa M.N., Lakwo T., Habomugisha P., Unnasch T.R., Garms R., Hudson-Davis L. After 70 years of fighting an age-old scourge, onchocerciasis in Uganda, the end is in sight. Int. Health. 2018;10(suppl_1):i79–i88. Epub 2018/02/23. - PubMed

Publication types